| NCT06720038 | A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants | RECRUITING | PHASE2 | 2024-11-25 | 2027-12 | 2027-12 |
| NCT06151288 | Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults | COMPLETED | PHASE1, PHASE2 | 2023-11-08 | 2024-07-17 | 2024-07-17 |
| NCT05844423 | Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants | COMPLETED | PHASE2 | 2023-03-29 | 2025-08-25 | 2025-08-25 |
| NCT05297578 | Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults | COMPLETED | PHASE2 | 2022-06-15 | 2023-02-15 | 2023-02-15 |
| NCT05266456 | Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults | COMPLETED | PHASE1, PHASE2 | 2022-02-22 | 2023-01-10 | 2023-01-10 |